HK5091A - Antiparasitic non-aqueous formulation containing an avermectin or milbemycin - Google Patents

Antiparasitic non-aqueous formulation containing an avermectin or milbemycin

Info

Publication number
HK5091A
HK5091A HK50/91A HK5091A HK5091A HK 5091 A HK5091 A HK 5091A HK 50/91 A HK50/91 A HK 50/91A HK 5091 A HK5091 A HK 5091A HK 5091 A HK5091 A HK 5091A
Authority
HK
Hong Kong
Prior art keywords
avermectin
milbemycin
antiparasitic
formulation containing
aqueous formulation
Prior art date
Application number
HK50/91A
Other languages
English (en)
Inventor
James B Williams
Russell U Nesbitt
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of HK5091A publication Critical patent/HK5091A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK50/91A 1983-12-22 1991-01-10 Antiparasitic non-aqueous formulation containing an avermectin or milbemycin HK5091A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56414083A 1983-12-22 1983-12-22

Publications (1)

Publication Number Publication Date
HK5091A true HK5091A (en) 1991-01-18

Family

ID=24253315

Family Applications (1)

Application Number Title Priority Date Filing Date
HK50/91A HK5091A (en) 1983-12-22 1991-01-10 Antiparasitic non-aqueous formulation containing an avermectin or milbemycin

Country Status (17)

Country Link
EP (1) EP0146414B1 (xx)
JP (1) JPH0623100B2 (xx)
KR (1) KR880002366B1 (xx)
AT (1) ATE47522T1 (xx)
AU (1) AU560864B2 (xx)
CA (1) CA1267844A (xx)
DE (1) DE3480263D1 (xx)
DK (1) DK164772C (xx)
ES (1) ES8608888A1 (xx)
GR (1) GR81244B (xx)
HK (1) HK5091A (xx)
IE (1) IE57681B1 (xx)
IL (1) IL73800A (xx)
NZ (1) NZ210505A (xx)
PT (1) PT79656B (xx)
SG (1) SG97890G (xx)
ZA (1) ZA849841B (xx)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0284176B1 (en) * 1987-01-23 1993-08-25 Pfizer Inc. Process for production of avermectins and cultures therefor
US5075307A (en) * 1987-07-28 1991-12-24 Merck & Co., Inc. Paraherquamide and dihydroparaherquamide as antihelminthic agents
GB8803836D0 (en) * 1988-02-18 1988-03-16 Glaxo Group Ltd Compositions
US6001822A (en) * 1989-04-11 1999-12-14 Pfizer Inc. Antiparasitic formulations
US5169846A (en) * 1989-10-12 1992-12-08 Crooks Michael J Non-aqueous micellar solutions of anthelmintic benzimidazoles, closantel, or phenothiazine, and insect growth regulators
NZ335166A (en) 1999-04-14 2001-11-30 Ashmont Holdings Ltd Anthelmintic composition containing triclabendazole in at least one solvent
GB2275193A (en) * 1993-02-17 1994-08-24 Merck & Co Inc Formulations for the topical delivery of avermectins
PL174488B1 (pl) * 1993-05-10 1998-08-31 Merck & Co Inc Preparat do zwalczania pasożytów zwierząt oraz sposób wytwarzania preparatu do zwalczania pasożytów zwierząt
US5602107A (en) * 1993-05-10 1997-02-11 Merck & Co., Inc. Pour-on formulations consisting of gylcols, glycerides and avermectin compounds
EP0697814B1 (en) * 1993-05-10 2003-07-30 Merck & Co. Inc. Pour-on formulations containinng polymeric material, glycols and glycerides
DE19613972A1 (de) * 1996-04-09 1997-10-16 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
DE19638045A1 (de) * 1996-09-18 1998-03-19 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen
ZA981925B (en) * 1997-03-21 1998-10-23 Biogenesis S A A long acting injectable parasiticidal composition and the process for its preparation
UY25089A1 (es) * 1997-07-10 2000-08-21 Hoechst Roussel Vet Gmbh Vacunas no acuosas
GB9816132D0 (en) * 1998-07-24 1998-09-23 Norbrook Lab Ltd Non-aqueous anthelmintic composition
AU733095B3 (en) * 1999-09-22 2001-05-03 Ashmont Holdings Limited Sheep pour on
JP2001253824A (ja) * 2000-03-14 2001-09-18 Mitsukazu Matsumoto 局所注射用処方剤
GR1003969B (el) * 2001-02-05 2002-08-14 U��-Pharma ����� ������ ������������ ���������� ���� Σταθερα φαρμακευτικα διαλυματα νιμεσουλιδης.
US20050009762A1 (en) 2003-06-06 2005-01-13 Strobel Michael Albert Application of water and organic solvent soluble ivermectin for topical and oral use
US6627613B2 (en) 2001-07-23 2003-09-30 Michael A. Strobel Application of water and organic solvent soluble ivermectin for topical and oral use
GB2386066A (en) 2002-02-28 2003-09-10 Norbrook Lab Ltd Long-acting parasiticidal composition with improved bioavailability comprising a salicylanilide, a further anti-parasitic compound & a polymeric species
UY27412A1 (es) * 2002-08-12 2003-06-30 Carlson Internat Inc Un nuevo producto para el combate de garrapatas y el proceso para la prepaacinn.
GB0316377D0 (en) 2003-07-12 2003-08-13 Norbrook Lab Ltd Parasiticidal composition
JP4886214B2 (ja) * 2005-05-24 2012-02-29 日本パワーファスニング株式会社 石膏ボード締結用の２条式木ねじ
MX2011003720A (es) 2008-10-08 2011-04-28 Wyeth Llc Composiciones antihelminticas de bencimidazol.
JP5607114B2 (ja) 2012-06-26 2014-10-15 株式会社トープラ タッピンねじ
EP4337015A1 (en) 2021-05-14 2024-03-20 Syngenta Crop Protection AG Insect, acarina and nematode pest control
WO2022268815A1 (en) 2021-06-24 2022-12-29 Syngenta Crop Protection Ag Insect, acarina and nematode pest control

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144352A (en) * 1977-12-19 1979-03-13 Merck & Co., Inc. Milbemycin compounds as anthelmintic agents
US4130651A (en) * 1978-03-31 1978-12-19 American Cyanamid Company Butamisole injectable formulations having improved margin of safety in dogs
NZ197796A (en) * 1980-08-04 1984-11-09 Merck & Co Inc Stabilised aqueous formulations containing ivermectin
US4430329A (en) * 1982-05-17 1984-02-07 Merck & Co., Inc. Synergistic treatment of adult canine heartworm with thiacetarsamide and ivermectin

Also Published As

Publication number Publication date
IE843221L (en) 1985-06-22
DK164772C (da) 1993-01-04
GR81244B (en) 1985-04-16
DK619784A (da) 1985-06-23
EP0146414A3 (en) 1986-12-10
PT79656B (en) 1987-01-16
KR880002366B1 (ko) 1988-11-03
ES8608888A1 (es) 1986-07-16
DK164772B (da) 1992-08-17
DK619784D0 (da) 1984-12-21
ES538750A0 (es) 1986-07-16
ATE47522T1 (de) 1989-11-15
AU560864B2 (en) 1987-04-16
SG97890G (en) 1991-02-14
EP0146414A2 (en) 1985-06-26
IE57681B1 (en) 1993-02-24
JPS60169415A (ja) 1985-09-02
KR850004391A (ko) 1985-07-15
DE3480263D1 (en) 1989-11-30
NZ210505A (en) 1988-06-30
PT79656A (en) 1985-01-01
JPH0623100B2 (ja) 1994-03-30
ZA849841B (en) 1986-07-30
AU3702484A (en) 1985-07-04
EP0146414B1 (en) 1989-10-25
IL73800A0 (en) 1985-03-31
IL73800A (en) 1987-11-30
CA1267844A (en) 1990-04-17

Similar Documents

Publication Publication Date Title
DE3480263D1 (en) Antiparasitic non-aqueous formulation containing an avermectin or milbemycin
IE811751L (en) Aqueous formulation
WO2001024763A3 (en) Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
IT1173705B (it) Formulazione farmaceutica di clometacina per somministrazione orale e procedimento di preparazione
CA2004598A1 (en) Medicinal aerosol formulations
EP0222614A3 (en) Orally administerable sustained release pharmaceutical formulations
IT8323956A0 (it) Antibiotici macrolidi e preparazione orale stabile di procedimento di stabilizzazione.
DE69528080T2 (de) Lösliche arzneizusammensetzungen enthaltend 2-chloro-2'-deoxyadenosine
NO168648C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive nitrogenholdige derivater av epipodofyllotoksin-glukosidderivater.
EP0085501A3 (en) Improvements in pesticidal formulations
GR3002420T3 (en) Medicinal formulation
IE811594L (en) Pharmaceutical formulations
NO167573C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive (5r, 6s,)-6-((r)-1-hydroksyetyl)-2-azacykloalkyltio-2-penem-3-karboksyl-syrederivater.
NO160142C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive (1,2,4)triazolo(4,3-a)kinoksalin-4-amin-derivater.
GR68699B (xx)
EP0093497A3 (en) Anthelmintic treatment
NO166366C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cycloalkan (1,2-c:4,3-c')dipyrazoler.
WO1987003590A1 (en) Medicament for the treatment of diseases of the liver
NO158062C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrido (1,4)benzodiazepiner.
JPS53124267A (en) 1-alkoxyacyl-3-(3,5-dihalogenophenyl)hydantoin derivatives, their preparation and bactericides for agricultural and horticultural uses containing the same as active agent
GB2162746A (en) Antiacidotic medicinal agent
AU555803B2 (en) 6 amino-1,5-dihydro-4h-imidazo(4,5-c) pyridin-4-one salts
AR241110A1 (es) Derivados de trihaloimidazol, composiciones insecticidas que los contienen como agente activo y metodo para producirlos.
IT1255696B (it) Composto con attivita' vasodilatatrice procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono
TH22662B (th) สารสูตรผสมของ 2-คลอโร-2'-ดีออกซิแอดีโนซินชนิดละลายได้

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20041220